[{"Assets_0_Q3_USD":23671500000.0,"EarningsPerShareBasic_3_Q3_USD":55.42,"EarningsPerShareBasic_1_Q3_USD":15.37,"EarningsPerShareDiluted_3_Q3_USD":52.29,"EarningsPerShareDiluted_1_Q3_USD":14.33,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":4708800000.0,"NetIncomeLossConverted_3_Q3_USD":5846300000.0,"NetIncomeLossConverted_1_Q3_USD":1632200000.0,"RevenuesConverted_1_Q3_USD":3452800000.0,"RevenuesConverted_3_Q3_USD":11120000000.0,"StockholdersEquity_0_Q3_USD":17258000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":111800000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":113900000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":105500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":106200000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS, INC.","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20211104"}]